We doubled our mammalian cell culture capacity in Europe!
Get More Info
About Us
Our Company
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Search
Search
Toggle Menu
Search
Search
Toggle Menu
About Us
Toggle Menu
Our Company
Executive Leadership
Locations
Toggle Menu
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
Toggle Menu
COVID-19 Response
Environment, Health & Safety
Group Privacy Policies
Our Services
Toggle Menu
Offerings
Toggle Menu
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Toggle Menu
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
News & Resources
Toggle Menu
Press Releases
Events
Thought Leadership
Resources
Toggle Menu
Case Studies
Fact Sheets
Video Library
Media Kit
Careers
Toggle Menu
Job Openings
Life at a CDMO
Diversity, Equity & Inclusion
Seattle Team
Boulder Team
Longmont Team
Copenhagen Team
Heidelberg Team
Milan Team
Chiba Team
Our Company
About Us
Our History
Mission & Values
Executive Leadership
Locations
Global Facilities Network
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
Policies
COVID-19 Policies
Environment, Health & Safety
Group Privacy Policies
Offerings
Mammalian
Microbial
pDNA
Viral Vector
Cell Therapy
mRNA
Services
Tech Transfer
Process Development
Analytical Development
Formulation Development
Process Validation
cGMP Manufacturing
Quality Systems & Inspection Management
Fact Sheets
Global Manufacturing Capabilities (PDF)
CHEF1
TM
Expression Technology (PDF)
Analytical, Formulation and Stability (PDF)
Process Development (PDF)
Cell Therapy Capabilities (PDF)
Viral Vector Capabilities (PDF)
Plasmid DNA Capabilities (PDF)
Messenger RNA Capabilities (PDF)
News
Press Releases
Events
Thought Leadership
Resources
Case Studies
Fact Sheets
Video Library
Media Kit
Join Us
Career Opportunities
What Drives Us
Life at a CDMO
Diversity, Equity and Inclusion
Meet Our Teams
Seattle
Boulder
Longmont
Copenhagen
Heidelberg
Milan
Chiba
2 min read
Takara Bio Selects AGC Biologics as Manufacturer of Plasmid DNA Intermediate for a Vaccine Against COVID-19 (SARS-CoV-2)
May 20, 2020 at 11:00 PM
News
Read More
2 min read
AGC Biologics to Participate in First-Ever BIO Digital Conference
May 13, 2020 at 6:16 PM
News
Read More
2 min read
AGC Biologics Partners with Faron Pharmaceuticals to Manufacture Cancer Treatment
May 5, 2020 at 1:47 PM
News
Read More
AGC Biologics Manufactures Key Ingredient in Potential COVID-19 Treatment Drug, Leronlimab
April 29, 2020 at 3:49 PM
News
Read More
2 min read
AdaptVac Partners with AGC Biologics to Develop & Produce COVID-19 Vaccine
April 24, 2020 at 5:00 AM
News
Read More
1 min read
AGC Biologics to Participate in Virtual BIO-Europe Spring
April 21, 2020 at 6:11 PM
News
Read More
BIO International Convention goes Virtual June 8 - 11, 2020
April 19, 2020 at 5:56 PM
Events
Read More
BioProcess International European Summit, July 13-16, 2020, Amsterdam
April 19, 2020 at 5:54 PM
Events
Read More
MIXiii BIOMED, September 7-9, 2020, Tel Aviv, Israel
April 19, 2020 at 12:31 PM
Events
Read More
Bio-Europe will be held October 26 - 28, 2020, Munich Germany
April 19, 2020 at 11:44 AM
Events
Read More
Prev
1
2
3
4
Next
